Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.

Rauch A, Laird R, McKinnon E, Telenti A, Furrer H, Weber R, Smillie D, Gaudieri S; Swiss HIV Cohort Study.

Tissue Antigens. 2007 Apr;69 Suppl 1:237-40.

PMID:
17445209
2.

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M.

Science. 2004 Aug 6;305(5685):872-4.

3.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

4.

Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.

López-Vázquez A, Rodrigo L, López-Larrea C.

Tissue Antigens. 2007 Apr;69 Suppl 1:241-2. Review.

PMID:
17445210
5.

Immunology. NK cells lose their inhibition.

Parham P.

Science. 2004 Aug 6;305(5685):786-7. No abstract available.

PMID:
15297654
6.

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC.

J Immunol. 2007 Nov 1;179(9):5977-89. Erratum in: J Immunol. 2007 Dec 15;179(12):8570.

7.

KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.

Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Sell AM, Visentainer JE, Moliterno RA.

Hum Immunol. 2011 Nov;72(11):1074-8. doi: 10.1016/j.humimm.2011.08.017. Epub 2011 Aug 28.

PMID:
21920398
8.

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.

Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT.

Mol Immunol. 2005 Feb;42(4):557-60. Review.

PMID:
15607813
9.

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.

López-Vázquez A, Rodrigo L, Martínez-Borra J, Pérez R, Rodríguez M, Fdez-Morera JL, Fuentes D, Rodríguez-Rodero S, Gonzáez S, López-Larrea C.

J Infect Dis. 2005 Jul 1;192(1):162-5. Epub 2005 May 25.

PMID:
15942906
10.

Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.

Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, Wilson MJ, Trowsdale J, Gladman D, Carrington M.

J Immunol. 2002 Sep 15;169(6):2818-22.

11.

Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus.

Paladino N, Flores AC, Marcos CY, Fainboim H, Theiler G, Arruvito L, Williams F, Middleton D, Fainboim L.

Tissue Antigens. 2007 Apr;69 Suppl 1:109-11.

PMID:
17445180
12.

Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.

Vejbaesya S, Nonnoi Y, Tanwandee T, Srinak D.

J Med Virol. 2011 Oct;83(10):1733-7. doi: 10.1002/jmv.22153. Epub 2011 Jul 13.

PMID:
21755501
13.

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M.

Nat Genet. 2002 Aug;31(4):429-34. Epub 2002 Jul 22.

PMID:
12134147
14.

Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.

Du Z, Gjertson DW, Reed EF, Rajalingam R.

Immunogenetics. 2007 Jan;59(1):1-15. Epub 2006 Nov 14.

PMID:
17103212
15.

Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection.

Neumann-Haefelin C, Thimme R.

Genes Immun. 2007 Apr;8(3):181-92. Epub 2007 Jan 18. Review.

PMID:
17230195
16.

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.

Naumova E, Mihaylova A, Ivanova M, Mihailova S.

Cancer Immunol Immunother. 2007 Jan;56(1):95-100. Epub 2006 Mar 18. Review.

PMID:
16547704
17.

HLA-C/KIR genotypes in oral lichen planus patients infected or non-infected with hepatitis C virus.

Carrozzo M, Elia A, Mereu V, Dametto E, Fasano M, Broccoletti R, Rendine S, Amoroso A.

Oral Dis. 2011 Apr;17(3):309-13. doi: 10.1111/j.1601-0825.2010.01742.x. Epub 2010 Sep 23.

PMID:
20860769
18.

HLA-C and KIR genes in hepatitis C virus infection.

Montes-Cano MA, Caro-Oleas JL, Romero-Gómez M, Diago M, Andrade R, Carmona I, Aguilar Reina J, Núñez-Roldán A, González-Escribano MF.

Hum Immunol. 2005 Nov;66(11):1106-9. Epub 2006 Mar 9.

PMID:
16571411
19.

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.

Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.

Tissue Antigens. 2007 Apr;69 Suppl 1:42-5.

PMID:
17445161
20.

Frequency of killer cell immunoglobulin-like receptors (KIRs) in Korean patients with chronic HCV infection.

Sung PS, Choi HB, Kim SY, Hong SW, Park CH, Song MJ, Lee SW, Yoo CR, Choi SW, Han NI, Kim TG, Yoon SK.

J Korean Med Sci. 2011 Nov;26(11):1483-8. doi: 10.3346/jkms.2011.26.11.1483. Epub 2011 Oct 27.

Supplemental Content

Support Center